Recent Articles

• 
  Biotech

  KAERI Extracts Lawn Anti-Hair Loss Compound for Products

  The Korea Atomic Energy Research Institute (KAERI) announced on the 5th that a functional cosmetic product to alleviate hair loss symptoms, using as its main ingredient a natural material extracted from centipedegrass, a type of turfgrass, has finally passed the Ministry of Food and Drug Safety revi

  2026.07.06
• 
  Bioprocessing / CDMO

  Lotte Chairman Shin Targets Global Bio Contracts

  On July 3, Lotte Group Chairman Shin Dong-bin visited Plant 1 of the Lotte Biologics Songdo Campus, located in Yeonsu-gu, Incheon, to conduct on-site management. Chairman Shin (second from left) is being briefed on the production process in front of a 15,000-liter bioreactor in the plant’s productio

  2026.07.05
• 
  Celltrion

  Celltrion Q2 Margin 33%, Growth Back on Track

  Celltrion announced on the 3rd that on a consolidated basis for the second quarter of this year, it posted provisional results of KRW 1.3 trillion in revenue and KRW 430 billion in operating profit. Compared with the same period last year, revenue increased 35.2% and operating profit 77.3%, reflecti

  2026.07.03
• 
  Medical / Clinical Case

  Daewoong’s Fexuclu Shows 96% Symptom Relief, Safe for Elderly

  Daewoong Pharmaceutical headquarters building. Provided by Daewoong Pharmaceutical Daewoong Pharmaceutical’s gastroesophageal reflux disease (GERD) treatment Fexuclue has shown a symptom improvement effect at a level of 96% in real-world clinical data that reflect the characteristics of actual medic

  2026.07.03
• 
  AI Healthcare

  Lemon Healthcare Launches ‘MyScanView’ to Replace CDs

  The era of “patient-centered medical MyData,” in which patients proactively manage and utilize their own medical data, is fully underway. Following medical records and health checkup results, even large-volume medical images stored on CDs—long regarded as a major challenge for digital transformation

  2026.07.03
• 
  AI Healthcare

  JINTS Bio Selected for Ministry Scale-up TIPS AI Drug Development Upgrade

  J-INTS Bio and Scale-up TIPS logos. Courtesy of J-INTS Bio Artificial intelligence (AI) drug discovery company J-INTS Bio has been selected for a technology development support program by the Ministry of SMEs and Startups. The company plans to advance its technology to identify potential therapeutic

  2026.07.03
• 
  Global Business

  Daewoong Pharma Launches Diabetes Drug Envlo in 8 MEA Nations

  ⓒNewsis Daewoong Pharmaceutical’s domestically developed diabetes treatment “Enblo” is entering eight major markets in the Middle East and Africa. Daewoong Pharmaceutical announced on the 2nd that it had signed an export supply contract for Enblo worth KRW 145.2 billion with Swiss pharmaceutical com

  2026.07.03
• 
  Medical / Research

  Depressed Women Under 45 Face 20% Higher Fatty Liver Risk

  A study has found that the more severe depressive symptoms are, the higher the risk of developing fatty liver. In particular, among women under 45, the association between depressive symptoms and fatty liver risk appeared more pronounced. Getty Images Bank The more severe depressive symptoms are, th

  2026.07.01
• 
  Global Trend

  Anthropic Enters AI Drug Race With Claude Science

  On the 30th (local time), Anthropic unveiled its automated drug discovery software (SW), “Claude Science,” at an event in San Francisco, United States. The company has entered the artificial intelligence (AI) drug development competition, a field where Google and OpenAI have taken an early lead. Wit

  2026.07.01
• 
  Medical / Research

  Seven Hours of Sleep? Data on 270,000 Challenge Belief

  Photo = Getty Images Bank Contrary to the common belief that “seven hours of sleep a day is necessary,” new research has found that there is no single “correct” sleep duration that can be uniformly applied to everyone.A joint research team from Sungshin Women’s University, Samsung Medical Center, Sa

  2026.06.30